http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101373653-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-15 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-738 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-738 |
| filingDate | 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101373653-B1 |
| titleOfInvention | Composition for the prevention and treatment of prostatic hyperplasia comprising a glycolysis extract |
| abstract | The present invention relates to a composition for preventing and treating prostatic hyperplasia comprising a glycolysis extract, the glycolysis extract of the present invention is extracted from a 12-week-old SD rat liver in which the prostate hypertrophy of the human prostate cancer cell line, the prostate hypertrophy is induced Inhibition of 5-alpha-reductase Types 1 and 2, Inhibition of 5RD Activity and PSA mRNA Expression in 5RD Type 2 Overexpressing Prostate Cell Lines, and COX-2, iNOS, IL -6, IL-1beta and so on, it shows a reducing effect can be useful in pharmaceutical compositions and health functional foods for the prevention and treatment of enlarged prostate. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104997873-A |
| priorityDate | 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 328.